Attend the Young Member Group Business Meeting during the #MDSCongress to share ideas for the upcoming year. This is a great opportunity for members under 40 to get involved with the society. loom.ly/zxF3nSo

It was great to have Njideka on the #MDSPodcast !

Njide Okubadejo thank you for joining and highlighting the great value of our society for all the movement disorders community.
MDS

The 2023 update of the #Parkinsons disease drug therapies in the clinical trial pipeline is now available at Journal of Parkinson's Disease - from Kevin McFarthing SueB Gary Rafaloff Brian Fiske michaeljfox.org & the research team at Cure Parkinson's
content.iospress.com/articles/journ…

It is finally online.

Co-editor @LudyShih and I thank the wonderful authors for an incredible diagnostic approach through phenomenology, as well as poignant related topics.

Link: thieme-connect.com/products/ejour…

A 🧵on topics

#NeuroTwitter #MedTwitter

🔴 Nos complace anunciar el nº 1-2023 de KRANION

- El cerebro humano en la era digital
- Consenso AMN sobre AMC en migraña
- El suicidio en 🇪🇸
- Antidepresivos y cognición en EA
- Ximur, un musical escolar sobre EA

kranion.es/portadas/krani…

Gracias por compartir 🔁❤️

Look 👀 we’re famous!

open.spotify.com/episode/2femKn…

This podcast focuses on the application of instrumented socks, a type of wearable sensor, for collecting movement pattern data of PD patients. Lead author Prof. Shah discusses how this data can be used to identify digital biomarkers to predict future falls loom.ly/xz1KX3g

Dr. Anthony Lang and Dr. Gennaro Pagano discuss the possible future perspectives of two clinical trials with antibodies targeting alpha-synuclein in early Parkinson's disease. loom.ly/tBc3450

Dystonia presents in a wide range of populations, from children to the elderly. In the latest podcast, Dr. Jill Ostrem highlights leading pharmacological and surgical dystonic therapies and the mechanisms behind their efficacy. Francesca Morgante loom.ly/L6CCqWQ

Really looking forward to 2nd MDCP conference in Kolkatta in a few days and the MDSI and AOPMC meeting - topics dealing with disparities and inequities in therapies & diagnostic tests in under privileged areas & how we should cope/address these issues

The MDS podcast celebrated its 100th episode this week! Thank you to our Podcast Editorial Board.

Watch the top moments from the first 100 episodes: loom.ly/rpsJHOU

Congratulations to Michele Matarazzo, Sara Schaefer and all of the MDS Podcast Editorial Board on this milestone achievement! movementdisorders.org/MDS/Podcasts.h…

Michele Matarazzo Congratulations on this tremendous achievement, Dr. Matarazzo (and the entire Editorial Board)!

open.spotify.com/episode/3dvh7A…

Trainees in movement disorders and early career faculty, please make use of the MDS roadmap. Such amazing educational content is available on the MDS website. Membership free for trainees.
MDS
Oscar Gershanik
Professor Carolyn Sue
Shivam Om Mittal, MD
Abhimanyu Mahajan

🎧: In 1970, the Venezuela Huntington's Disease Project set out to research and support a rural village with an unusually large #HD population. Dr. David Standaert MD, PhD shares about his experiences in the project, and how it shaped #HD medicine. Sara Schaefer, MD, MHS loom.ly/2hUAGhs

Focused ultrasound (FUS) has been used together with intravenous injections to disrupt the BBB to target specific brain regions in AD and PD patients. Dr. Pineda-Pardo discusses his most recent FUS safety study for PD dementia patients. loom.ly/gNX4BDg Movement Disorders Journal